RSbA Indepd•t Auditorfs Roport RSMUS LLP Board of Dirgctors OBI Holding Coryany Oplnlon We have audited the consolidated fman¢i?I statemerts of OBI Hddlng c¢panY arKI its 8ubsidiarie& Ith8 Company}, which comprise the consolKlaled stslements of finala1 posrtitsn a$ of March 31, 2022 and 2021. and the related con&YKlated stslenwnls ol actt¥. functional expenses and cash fl¢)ws for the years then ended. and the relatèd nol88 to the conaolidaled financial Statements IcollectNely the finwKtal slatementsl. In our opin. the aCcPanY1n9 financol statermrts PrenI fairty, in 1 material Te¥pects. the finan¢ial posth'on of the Company as of March 31, 2022 and 2021. and the ¢hanges in rts net as8els and rt$ ¢a8h flows for the years then ended in accordance wrth xcounling prinPIeS gerwalty a¢¢epted in the United Sl8le8 ofAm¢ri¢a. Ba•1• for Oplnlon We ccrtu¢ted our audits in accordance with audng standards generalty accepted In the Unrted Slates of America IGAASI. Our r6$ponbI1lO3 under those standards are fvrthér described in the Audf(or's Responsibilities for the ALKlit ofthe FinarLkg1 Stslemenls 8eth.on of our report. We are raquired to b• independent of the Company and lo meet our other ethKal responsibilit. in accordanc8 wrth the relevant ethical requirements relating lo sjjr audit. We believe that the audrt ewdenGe wo have obtain 18 SLfftient and apprcpriato lo pmide a basw for our audrt ¢pinicm. RMponslbilltl•• of M•nagem•nt for th• Flnanclal Statem•nts Management is responsible lor the preparatn and fair preSentatn of the finaal slattsments in 3rdanCe with acecNJnting principles generally aceepled in the United Stes of America. and for It de8ign. implemenlalKin, and maintenanc8 of internal control rethnt to the preparalK)n and fair prosonlalion of financial statements that are free frcffi material mi8818tomenl, whether due lo fraud (x In preparing the financial statèments. management is r6yuir8d to evaluate whether the are conditions or events, considered in the aggwato, that Tai5e substantial doubt abwl the Company s ability to continue as a going c1ceM wrthin one year after the date that the financial ststements are issu&l or av8ilabk8 to be i8gue(l. Audltorf8 Respon8ibllltles fof tho Aud1¢ of th• FlnaDcial Statements Our objectrves are lo obtain reasonable assurance at¢•Lrt whether the finanual ststemonts as a whokn are free from Material mi55tement. whether due to fraLKI or error. an¢J lo issue an auditorfs report that includes our ¢Jpinion. Reasonable assurance is a h3b level of assuTan¢e but is not absolute assurance and therefo 1$ rnt a guarantee that an aLMJii conduded in ac¢ordanc8 wrth GAAS will aayS detect a material misstaEemenl when r( exists. The risk of not ¢Jete¢tiThJ a material misslalwnenl resU1ng from fraud is hher than for one resulting fr(xm error, as fraud may involve c(JIu$KJn. forgery, intentional omissions, misrepresentations, or the override c4 intemal contnA. MisStatnentS are considgred material rfthere is a substaAtial likelihood th81. indiv*Jualty or in the aggregate, th8y would influence the 1ment made by a reasonable user based C the finan¢iJ statements. THE POWER OF BEING UNDERSTOOD AUDIT I TAX I CONSULTING
In perfomiing an audit in accordance with GAAS, we.. Exercise professional judgrrnl maintain professtrJnal skepticism throughout the audit. Identify and assess the risks of material rnisstalement of the finanek41 atements, %thether due lo fraud or error. and design and rtr)rni audit procedures responswe to those risks. Such procedures include examining. on a t85t basis, evKience waT(ling the amnts and disclosures in the financial statements. Obtain an urKlerslanding of intemal control relevant to the audit in order to desHJn audit procedures that are appropriate in the circumstances, bul not for the purpose of expressing an opinion on th8 ffectiveness of the Company's intemal contrcA. Accordingty. such cpinion is expressed. Evaluate the approprleneSS of accounting poli¢s used and th• reasonableness of significant accounting 8$1imes made by man•3ement, as well as evaluate the overall presenlatH)n of tho financ*1 statements. Concltjde whether, in our judgment. there are condilion8 or ents. t$ere(l in the aggregate, that rai$• subslanlial doubl about the Foundatbon's abilty to continue as a goiThd nCern for a reasonable p8ri¢xl of lime. We are requ¥ed lo communle wrth th08è Charged with go¥emce regarding, among clher matters. the planned $¢ope and timing of the audrt. signrfunl audrt firing¥. and cartain int•mal controkelated matters that wa identified during the 8udrt. Okjahoma Cty, Oklahoma June 29, 2022
OBI Holdlng C¢)mpany Notes to Consolidated Flnanclal Statements Oryani2atlon Ind Summary ol Slgnlllc•nt AccountlTrg Policles Oryanlzatlon and naturo of 0tIOnS. OBI Holdin9 Company (HdIng) is an Oklahc¥na not-foirofit corporation, without PItal stock. Organed in 199). Holdin9 the sore member and has a controlling financial interest in the fOlking SUbslarIeS". Oklahuna BIc#>J Institute. Gk•bal Bh)GJ Fund. Thè Oklahoma Blocé Inslitute Foundation, OBI Real Estate Ccmpany, OBI Real Estate Ccfnpany 2, and Blo¢xl Institute Ventufes. LLC. Oklahoma Blood Institute Ilhe Inslrtute) was incorporated in April 1976 for the purpos8 of maintaining and supporting blood collection cenlers. The Instrtute provKles for the procurement of blood. blood Components and related s•rv¢¢$ vthich indudes the recrurtment of dorm and th& drawng. proce88iro. slofage and distribution of blcc4J, and bk43d components through ts centern lOted in Oklahoma Cty. Lwrton, Enid. Ardmre, Ada. and Tul8a, Oklahoma.. WKhrta Falls and Amarilk), Texas,. and Hol Springs and Lrttle Rock, Athansas. The Gthal Bld Fund was f¢Ymed in February 2008 to engago in Chwitab, educational and $Ctsf purposes. The Oklahoma 8lwJ InstrtLrte Foundation (the Foundalionl was ¢regted in Aprll 2C)O, aTrJ w08 ingcli until May 200S, to Ihe activrtie$, affairs and prcgram8 of the Instilule. The Institute, Gk)bal Bh)¢xl Fund and the Foundation are all nel-fOrrOIlt COfpNalwJns. wilhout capilal slcrtk. formed under the laws of the State of Oklahoma arKI are qualthed 501{cM31 public chsriiw. OBI Real Estate Company, a qualthed $01lcl{251 not-foT-profft 0rg8ntyn. and OBI Real Estate Company 2, 8 di5gar(1ed not-lor-profft limited li8bilty company. were organized In 1990 and 2008, respedively, for the purpose of hokling real property used by the Instilulo. Blood Institut8 Ventures. LLC. an Oklqhoma limited liability company. wa5 formed in Juno 2010 to pursuo certain bu8ino88 opportunit8. These entities are inactive. On janu 3. 2022 and NO¥boT 30. 2021. tho Cryny formgd CytoGrowth Solutions, LLC and BK Linked, LLC, respeclivety, Iboth disregarded Oklahfi0 r)ot-for-profrt limrted liability cnponl for tho purpose of supportirwj tho tharitab16 miss•, purposes. and xtsvilias of the solo mgmber. OBI Holding Ccmpany. Prln¢lple8 of conw)Ild•tlon: The con8didated finala1 BLknnts ho boen prepargd on the accrual basis of GntIng and include the as¥ets, liabilrts. nel assets and aCtIlIeS of Holding, the Instrtule, and the Foundation as of and for the years endiThJ March 31. 2022 and 2021. Global Blwd Fund has December 31 year end is Conso10ted as of and for the years ending December 31. 2021 and 2020. All synrficant inlercompany balances and transactions hove béon eliminaled in corrfolKlob"on. Hokling and rts subshdiaries are collectivdy referr to as the Company. U80 of Htlmat•s". The prep8r3tion of financial Stat?nIS. in ¢1mty fjth aeecAJnllng principle g¢neralty accepted in the United States of America, requiros management to make estimatas and assumptions that affect the repted anh)unl$ of assats and liabilit ond disclosure of contingent a$set$ and liabilities at the date of the finan¢o1 sLments and the rvportod aruntS of revenue$ and expenses during thg roporting pefd. Significant estimates include implKal pric8 con$10n$, valualion of invonlory, valuation of investments carried at fair value and fvnds held by communty foundion. impaiment of investments carr*d al ¢))sl, useful lives and impairment of kg-11ved assets, Trncurred bul not reported health and workers, c<rynsabon daim5. the dlocali of 8xp8nses on a functional basis. Actual resutts could dther from those estimat.
1/17/2023
Global Blood Fund Balance Sheet
1/2
Page
1:20 PM
Dec 31, 2022
ASSETS
| CURRENT ASSETS CASH & CASH EQUIVALENTS CIB - MIDFIRST INVESTMENT CIB - CHASE OPERATING-US CIB - CHASE OPERATING-UK CIB - BOK - OPERATING CIB - BOK - INVESTMENT TOTAL CASH ACCOUNTS RECEIVABLE ACCOUNTS RECEIVABLE TOTAL ACCOUNTS RECEIVABLE TOTAL ASSETS |
333,640.86 40,067.55 .00 .00 .00 |
|---|---|
| 373,708.41 8,770.76 |
|
| 8,770.76 382,479.17 |
1/17/2023
Global Blood Fund Balance Sheet
2/2
Page
1:20 PM
Dec 31, 2022
LIABILITIES AND EQUITY
| CURRENT LIABILITIES ACCOUNTS PAYABLE ACCOUNTS PAYABLE TOTAL ACCOUNTS PAYABLE DEFERRED INCOME DEFERRED INCOME TOTAL DEFERRED INCOME TOTAL LIABILTIES DONOR RESTRICTED GRANT FUNDS TOTAL DONOR RESTRICTED GRANT FUNDS UNRESTRICTED NET ASSETS TOTAL UNRESTRICTED NET ASSETS TOTAL FUND BALANCE TOTAL LIABILITIES & FUND BALANCE |
50,000.00 |
|---|---|
| 50,000.00 .00 |
|
| .00 50,000.00 68,765.00 263,714.17 |
|
| 332,479.17 382,479.17 |
1/17/2023
Global Blood Fund INCOME STATEMENT Dec 31, 2022
1/2
Page
1:22 PM
| YTD ACTUAL 140,731.97 .00 .00 .00 .00 .00 .00 .00 701.35 141,433.32 .00 .00 .00 .00 .00 .00 14,859.00 .00 .00 .00 .00 .00 .00 189,190.58 .00 .00 .00 |
YTD PRIOR 82,089.82 .00 .00 .00 .00 .00 .00 .00 1,160.77 83,250.59 .00 .00 .00 .00 .00 .00 35,525.51 .00 .00 .00 .00 .00 .00 173,551.72 .00 .00 .00 |
YTD BUDGET .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 |
VARIANCE % REVENUE DONATIONS 0.00 GRANTS - DESIGNATED 0.00 GRANTS - DESIGNATED 0.00 GRANTS - DESIGNATED 0.00 GRANTS - DESIGNATED 0.00 GRANTS - DESIGNATED 0.00 GRANTS - DESIGNATED 0.00 GRANTS - UNDESIGNATED 0.00 INTEREST INCOME 0.00 TOTAL REVENUE 0.00 EXPENSES INDIRECT, MARKETING & ADMIN. DONATION/GRANT EXPENSES 0.00 DONATION/GRANT EXPENSES 0.00 DONATION/GRANT EXPENSES 0.00 DONATION/GRANT EXPENSES 0.00 DONATION/GRANT EXPENSES 0.00 DONATION/GRANT EXPENSES 0.00 DONATION/GRANT EXPENSES 0.00 PROFESSIONAL FEES 0.00 PROFESSIONAL FEES 0.00 PROFESSIONAL FEES 0.00 PROFESSIONAL FEES 0.00 PROFESSIONAL FEES 0.00 PROFESSIONAL FEES 0.00 PROFESSIONAL FEES 0.00 PROFESSIONAL FEES 0.00 MARKETING EXPENSE 0.00 MARKETING EXPENSE 0.00 |
2ND PRIOR MO 5,963.61 .00 .00 .00 .00 .00 .00 .00 54.77 6,018.38 .00 .00 .00 .00 .00 .00 5,950.00 .00 .00 .00 .00 .00 .00 16,143.71 .00 .00 .00 |
PRIOR MONTH 10,013.85 .00 .00 .00 .00 .00 .00 .00 53.41 10,067.26 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 23,487.24 .00 .00 .00 |
CUR ACTUAL 02-5710-00 4,783.04 02-5711-00 .00 02-5711-01 .00 02-5711-02 .00 02-5711-03 .00 02-5711-04 .00 02-5711-05 .00 02-5712-00 .00 02-5820-00 90.90 4,873.94 02-6618-00 .00 02-6618-01 .00 02-6618-02 .00 02-6618-03 .00 02-6618-04 .00 02-6618-05 .00 02-6618-07 .00 02-6620-00 .00 02-6620-01 .00 02-6620-02 .00 02-6620-03 .00 02-6620-04 .00 02-6620-05 .00 02-6620-07 14,351.67 02-6620-09 .00 02-6707-00 .00 02-6707-07 .00 |
|---|---|---|---|---|---|---|
1/17/2023
Global Blood Fund INCOME STATEMENT Dec 31, 2022
2/2
Page
1:22 PM
| YTD ACTUAL .00 40.00 .00 1,047.00 .00 .00 .00 18,733.74 .00 .00 223,870.32 (82,437.00) |
YTD PRIOR .00 .00 .00 .00 .00 .00 .00 7,507.42 .00 .00 216,584.65 (133,334.06) |
YTD BUDGET .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 .00 |
2ND PRIOR MO VARIANCE % .00 MEETING EXPENSE 0.00 40.00 MEETING EXPENSE 0.00 .00 FREIGHT 0.00 .00 FREIGHT 0.00 .00 TAXES 0.00 .00 TAXES 0.00 .00 BANK SERVICE CHARGES 0.00 1,751.98 BANK SERVICE CHARGES 0.00 .00 CONVERSION RATE EXCHANGES 0.00 .00 CONVERSION RATE EXCHANGES 0.00 23,885.69 TOTAL INDIRECT, MARKETING & ADM 0.00 (17,867.31) REVENUE OVER EXPENSES 0.00 |
PRIOR MONTH .00 .00 .00 .00 .00 .00 .00 341.32 .00 .00 23,828.56 (13,761.30) |
|---|---|---|---|---|
Describe the organization's mission as articulated in its mission statement or otherwise adopted by the organization’s governing body.
GLOBAL BLOOD FUND (GBF) WORKS WITH LOW AND MIDDLE-INCOME COUNTRIES TO ENSURE A SAFE AND SUFFICIENT BLOOD SUPPLY FOR ALL. THIS IS ACHIEVED THROUGH THE PROVISION OF TRAINING, EQUIPMENT, GRANTS AND OTHER FORMS OF SUPPORT, WITH PARTICULAR FOCUS ON ENGAGING LOCAL CITIZENS IN VOLUNTARY NON-REMUNERATED BLOOD DONATION (VNRBD).
VNRBD IS RECOGNIZED BY THE WORLD HEALTH ORGANIZATION AND OTHERS AS THE MOST COSTEFFECTIVE WAY TO PREVENT THE HUNDREDS OF THOUSANDS OF DEATHS THAT RESULT EACH YEAR FROM BLOOD SHORTAGES. IT ALSO HELPS MITIGATE THE TRANSMISSION OF INFECTIONS (SUCH AS HIV, MALARIA AND HEPATITIS) THAT CAN BE CONTRACTED THROUGH BLOOD TRANSFUSION AND WHICH DEVASTATE LIVES AND FAMILIES.
Did your organization cease conducting, or make significant changes in how it conducts, any program services?
FOLLOWING THE DISRUPTION IN 2020 AND 2021 CAUSED BY THE GLOBAL PANDEMIC, GBF’S WORK IN 2022 WAS LESS IMPACTED BY COVID-19. TRAVEL TO FACILITATE OR DELIVER PROGRAM ACTIVITIES BECAME POSSIBLE ONCE AGAIN AND CAPACITY WITHIN RECIPIENT ORGANIZATIONS TO DELIVER PLANNED PROGRAMS IMPROVED. NETWORKING OPPORTUNITIES TO REBUILD PIPELINE ACTIVITIES WERE LESS RESTRICTED, ALTHOUGH THE CENTERPIECE AABB MEETING IN FLORIDA WAS CANCELLED AT THE LAST MINUTE DUE TO HURRICANE IAN. THE ‘NEW NORMAL’ OF 2021 (IN WHICH BLOOD
ESTABLISHMENTS HAD LARGELY ADAPTED TO THE NOVEL POST-COVID ENVIRONMENT BUT WERE LESS ENTERTAINING OF ANY PERCEIVED DISTRACTIONS TO NON-CORE ACTIVITY) DIMINISHED SOMEWHAT, BUT WAS STILL A NOTABLE FEATURE OF 2022.
AS COUNTRIES RE-OPENED, EQUIPMENT RE-HOMING BECAME POSSIBLE ONCE AGAIN, HELPED BY THE RETURN OF FREIGHT COSTS TO MORE NORMAL LEVELS FROM THEIR PRECIPITOUS COVID-HIGHS. WITH GETTING DONATIONS INTO MEXICO A COVID-ERA (AND POST-COVID ERA) CHALLENGE, A DECISION WAS MADE TO BROADEN THE FOCUS TO INCLUDE WIDER LATIN AMERICA. TO FACILITATE THIS, A SPANISH SPEAKING MEMBER OF STAFF WAS APPOINTED AS CO-ORDINATOR FOR THIS REGION.
GIVEN THAT DONATIONS TO THE CHARITY CONTINUE TO BE SPORADIC AND UNPREDICATABLE, A MORE STRUCTURED GIVING INITIATIVE HAS BEEN SCOPED, READY FOR IMPLEMENTATION IN 2023. UNDER THE ‘FRIENDS OF GLOBAL BLOOD FUND’ PROGRAM, SUPPORTERS WILL BE ENCOURAGED TO PLEDGE AN ANNUAL DONATION AMOUNT, A COMMITMENT WHICH WILL ROLL FORWARD FOR SUBSEQUENT YEARS UNTIL CANCELLED.
EXPANSION OF PARTNERSHIP NETWORK
MUCH OF GBF'S ACTIVITY RELATES TO ITS ABILITY TO CREATE AND GALVANIZE NETWORKS IN THE US, EUROPE, AND AUSTRALASIA (NATIONAL AND REGIONAL BLOOD SERVICES, INDUSTRY SUPPLIERS, REGULATORY BODIES ETC.) TO ASSIST DEVELOPING-WORLD BLOOD COLLECTION ORGANIZATIONS. WORKING BOTH DIRECTLY AND THROUGH PAN-NATIONAL AND PROFESSIONAL ASSOCIATIONS, GBF IS ABLE TO ASSEMBLE MULTI-AGENCY COLLABORATIONS, WITH OBJECTIVES AND CONFIGURATIONS DIFFERING BY PROJECT.
OVER THE PERIOD, CLOSE RELATIONSHIPS WERE NURTURED WITH AfSBT (AFRICA SOCIETY FOR BLOOD TRANSFUSION), ISBT (INTERNATIONAL SOCIETY FOR BLOOD TRANSFUSION), COBA (COALITION OF BLOOD FOR AFRICA), ADRP (ASSOCIATION OF BLOOD DONOR PROFESSIONALS), GCIAMT (GRUPO COOPERATIVO IBEROAMERICANO DE MEDICINA TRANSFUSIONAL), ETC. AS AN EXAMPLE OF ITS COLLARBORATIVE APPROACH, GBF ATTENDED THE GCIAMT MEETING IN COLOMBIA WHERE IT WAS AGREED THE CHARITY WOULD WORK WITH GCIAMT AND THE VENDOR COMMUNITY TO INCREASINGLY FOCUS ON SUPPORTING LATIN AMERICA WITH DONATED BLOOD MOBILES, AS WELL AS STAND UP A TRAINING PROGRAM IN THE US (HOSTING BY A US BLOOD CENTER PARTNER) FOR LATIN AMERICAN DELEGATES TO BE EXPOSED TO OPERATIONAL BEST PRACTICE. ELSEWHERE, GBF AGREED WITH DIAGAST – A FRENCH MANUFACTURER – TO JOINTLY SUPPORT A PILOT IN GHANA OF PRE-DONATION BLOOD TYPING AS A RECRUITMENT STRATEGY.
GBF’S PROFILE WAS ASSISTED IN 2022 BY THE DEPLOYMENT OF A GAMIFIED APPROACH TO GENERATING AWARENESS. BY OFFERING AND FREELY DEPLOYING ‘TIC-TAC-TRIVIA’ AS AN ADDED VALUE FEATURE AT INDUSTRY EVENTS, GBF WAS ABLE TO ACHIEVE A LEVEL OF VISBILITY ONLY OTHERWISE POSSIBLE BY INVESTING IN HUGELY EXPENSIVE SPONSORHIP OPPORTUNITIES.
RE-HOMING OF DISPLACED EQUIPMENT
RE-HOMING OF DISPLACED EQUIPMENT RETAINED ITS STATUS AS ONE OF THE MOST IMPORTANT PROGRAMS. GBF OWNS AND MANAGES ‘EXCHANGE’, A CLOUD-BASED PLATFORM ENABLING BLOOD SERVICES WORLDWIDE TO LIST EQUIPMENT AVAILABLE FOR DONATION. THIS TYPICALLY BECOMES AVAILABLE WHERE ITEMS ARE DISPLACED AS A CONSEQUENCE OF ROUTINE UPGRADE PROGRAMS, LEAVING STILL-SERVICEABLE EQUIPMENT SURPLUS TO LOCAL REQUIREMENTS.
AS WELL AS VIEWING AND RESPONDING TO OFFERS, THE SYSTEM OFFERS BLOOD SERVICES IN LOWINCOME COUNTRIES THE ABILITY TO LIST AND CIRCULATE THEIR SPECIFIC REQUIREMENTS WORLDWIDE. ONCE A MATCH IS MADE BETWEEN DONOR AND RECIPIENT, GBF MANAGES AND RESOURCES THE LOGISTICS OF RE-HOMING. DONATIONS MOSTLY COME FROM THE US AND EUROPE. RECIPIENTS ARE TYPICALLY BLOOD SERVICES IN AFRICA, LATIN AMERICA, AND ASIA.
EXAMPLES OF 2022 ACTIVITY INCLUDE CENTRIFUGES AND DONOR COUCHES SENT TO MEXICO, THOUSANDS OF T-SHIRTS SENT TO AFRICA AND SEVERAL BLOOD MOBILES SENT TO CENTRAL AMERICA.
NON-EQUIPMENT BASED SUPPORT
NON-EQUIPMENT BASED SUPPORT FORMS A MAJOR COMPONENT OF GBF’S OVERALL PACKAGE OF CHARITABLE ACTIVITY.
THE OUTBREAK OF WAR IN UKRAINE AT THE START OF THE YEAR PROMPTED A FOCUS ON THE NEEDS OF THAT COUNTRY, INITIALLY ON ADAPTING THE MENTORING PLATFORM SOFTWARE (SEE BELOW) TO MATCH REFUGEES WITH POTENTIAL HOST FAMILIES IN THE UK. IN DOING THIS, A NEW PARTNERSHIP WITH AN ORGANIZATION THERE, DONOR UA, DEVELOPED. SUBSEQUENTLY, AS WELL AS PROVIDING DIRECT FINANCIAL SUPPORT TO DONOR UA, AN INITIATIVE WAS DEVELOPED WHEREBY LUNCHES WERE PROVIDED TO STAFF AT DNIPRO BLOOD CENTER, A SYMBOLIC APPRECIATION FROM THE GLOBAL BLOOD BANKING COMMUNITY FOR THEIR BRAVERY AND HARD WORK. THIS EFFORT WAS FACILITATED THROUGH DONOR PROMOTIONS RUN BY SEVERAL BLOOD CENTER PARTNERS TO RAISE MONEY FOR UKRAINE-FOCUSED ACTIVITY.
"OPEN ARMS" PROGRAM
GBF'S "OPEN ARMS" PROGRAM GIVES BLOOD CENTERS ACROSS THE U.S. AND IN OTHER PARTS OF THE WORLD AN OPPORTUNITY TO OFFER THEIR BLOOD DONORS A CHARITABLE ALTERNATIVE TO THE USUAL RECOGNITION ITEMS OF PRINTED T-SHIRTS, ETC. THIS PROGRAM CREATES A VIRTUOUS CIRCLE OF ACTIVITY SUCH AS IMPROVING DONOR CHOICE, MOTIVATING COLLECTION STAFF, SAVING BLOOD CENTERS MONEY, PROVIDING A DIVERSITY PLATFORM TO ENCOURAGE BLOOD DONATION FROM MINORITY COMMUNITIES AND PROVIDING RESOURCES FOR INTERNATIONAL DEVELOPMENT WORK IN AN AREA OF INTEREST TO ALL PARTIES.
2022 SAW AN INCREASE IN BLOOD CENTER SUPPORTERS OFFERING TACTICAL SUPPORT ON A CAUSESPECIFIC BASIS ONLY, WITH A CORRESSPONDING REDUCTION IN CENTERS FACILITATING A ROUTINE GBF PRESENCE IN, FOR EXAMPLE, BRANDED ONLINE POINT-REDEMPTION STORES. BLOOD COLLECTORS ARE INCREASING LOOKING TO RAISE CHARITABLE FUNDS TO RESOURCE THEIR OWN CORE-MISSION, LEADING TO A REDUCTION IN THE WILLINGNESS TO ENCOURAGE THEIR DONORS AND OTHER STAKEHOLDERS TO GIVE TO THIRD-PARTY ORGANIZATIONS, HOWEVER RELEVANT THE CAUSE. IT SEEMS UNLIKELY THAT THIS TREND WILL REVERSE ANYTIME SOON.
TRAINING & EDUCATION
OF PARTICULAR NOTE IN 2022, GBF LAUNCHED THE PILOT OF A MENTORING PROGRAM, USING A SOFTWARE PLATFORM TO CONNECT BLOOD BANKING PRACTITIONERS IN THE US AND EUROPE WITH THEIR PROFESSIONAL EQUIVILENTS IN GHANA (THE PILOT PARTNER).
GBF’S ONLINE TRAINING COURSE – FOCUSING ON DONOR RECRUITMENT, EDUCATION AND CERTIFICATION – CONTINUES TO ATTRACT SIGNIFICANT NUMBERS. THIS REMOTE LEARNING INITIATIVE OFFERS SIX HOURS/12 MODULES OF VIDEO CONTENT. SEVERAL HUNDRED ENROLEES HAVE NOW COMPLETED THE PROGRAM.